TipRanks
BridgeBio Pharma Inc (DE:2CL)
XETRA:2CL

Compare BridgeBio Pharma (2CL) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
BridgeBio Pharma
€67.37
€11.45B
-18.64
32.23%
16 Buy
1 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.61B
154.82
6.53%
17 Buy
5 Hold
0 Sell
Strong Buy
Ionis Pharmaceuticals
$63.57
$7.42B
-12.75
-33.13%
17 Buy
4 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.92B
-12.44
-9.06%
4 Buy
9 Hold
4 Sell
Hold
PTC Therapeutics
$73.47
$5.41B
-131.69
3.42%
8 Buy
1 Hold
1 Sell
Moderate Buy
Ultragenyx Pharmaceutical
$26.46
$1.48B
-2.54
-50.82%
10 Buy
10 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2CL
BridgeBio Pharma
58.54
13.28
29.34%
BMRN
BioMarin Pharmaceutical
58.44
3.01
5.43%
IONS
Ionis Pharmaceuticals
44.00
-25.15
-36.37%
SRPT
Sarepta Therapeutics
17.57
-5.07
-22.39%
PTCT
PTC Therapeutics
64.13
-1.24
-1.90%
RARE
Ultragenyx Pharmaceutical
14.75
-16.46
-52.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts